Regis Resources (ASX: RRL) drops Vault Minerals bid, letting Genesis Minerals’s A$5.6bn offer proceed
Read More Pharma Industry News Is Ocular Therapeutix the next big biotech buyout? Takeover rumors spark investor frenzy Ocular Therapeutix stock jumps on takeover rumors. Find out what analysts are saying, and why Axpaxl could make it biotech’s next big M&A target. byPallavi MadhirajuSeptember 7, 2025